Literature DB >> 28657988

Vaginal Uterosacral Ligament Suspension: A Retrospective Cohort of Absorbable and Permanent Suture Groups.

Megan S Bradley, Jennifer A Bickhaus, Cindy L Amundsen, Laura K Newcomb, Tracy Truong, Alison C Weidner, Nazema Y Siddiqui.   

Abstract

OBJECTIVE: The aim of this study was to compare anatomic results after vaginal uterosacral ligament suspension with absorbable versus permanent suture.
METHODS: We performed a retrospective cohort study of women who underwent vaginal uterosacral ligament suspension, from 2006 to 2015. We compared 2 groups: (1) absorbable suspension suture and (2) permanent suspension suture (even if accompanied by absorbable suture). Our primary outcome was composite anatomic failure defined as (1) recurrent prolapse in any compartment past the hymen or (2) retreatment for prolapse. Continuous variables were analyzed using the Student t test or Mann-Whitney U test, and categorical variables were analyzed using χ or Fisher exact test. Multivariable logistic regression analysis was performed to control for confounders. P < 0.05 was considered significant.
RESULTS: Of the 242 patients with medium-term follow-up (3 months to 2 years after surgery), 188 underwent vaginal uterosacral ligament suspension with only absorbable suture, and 54 underwent suspension with permanent suture. Compared with the absorbable suture cohort, the permanent suture cohort was more likely to have had advanced preoperative prolapse (P = 0.01), less likely to have had a prior hysterectomy (P = 0.01), and less likely to have undergone a concomitant posterior colporrhaphy/perineoplasty (P < 0.01). Overall, there were no differences in composite anatomic failure between the absorbable and permanent suture groups (17.0% vs 20.4%, P = 0.41). In multivariable logistic regression analyses, when controlling for covariates, there remained no difference in composite anatomic failure between permanent and absorbable suture groups.
CONCLUSIONS: Completion of vaginal uterosacral ligament suspension using only absorbable suture affords similar anatomic outcomes in the medium term as compared with suspension with additional permanent suture.

Entities:  

Mesh:

Year:  2018        PMID: 28657988      PMCID: PMC5745319          DOI: 10.1097/SPV.0000000000000451

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  24 in total

1.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

2.  The Design of a Randomized Trial of Vaginal Surgery for Uterovaginal Prolapse: Vaginal Hysterectomy With Native Tissue Vault Suspension Versus Mesh Hysteropexy Suspension (The Study of Uterine Prolapse Procedures Randomized Trial).

Authors:  Charles W Nager; Halina Zyczynski; Rebecca G Rogers; Matthew D Barber; Holly E Richter; Anthony G Visco; Charles R Rardin; Heidi Harvie; Dennis Wallace; Susan F Meikle
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Jul-Aug       Impact factor: 2.091

3.  Uterosacral ligament vaginal vault suspension using delayed absorbable monofilament suture.

Authors:  Micheline J Wong; Azadeh Rezvan; Narender N Bhatia; Tajnoos Yazdany
Journal:  Int Urogynecol J       Date:  2011-06-17       Impact factor: 2.894

4.  High levator myorraphy versus uterosacral ligament suspension for vaginal vault fixation: a prospective, randomized study.

Authors:  Franca Natale; Chiara La Penna; Anna Padoa; Massimo Agostini; Massimo Panei; Mauro Cervigni
Journal:  Int Urogynecol J       Date:  2010-02-26       Impact factor: 2.894

5.  Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial.

Authors:  Matthew D Barber; Linda Brubaker; Kathryn L Burgio; Holly E Richter; Ingrid Nygaard; Alison C Weidner; Shawn A Menefee; Emily S Lukacz; Peggy Norton; Joseph Schaffer; John N Nguyen; Diane Borello-France; Patricia S Goode; Sharon Jakus-Waldman; Cathie Spino; Lauren Klein Warren; Marie G Gantz; Susan F Meikle
Journal:  JAMA       Date:  2014-03-12       Impact factor: 56.272

6.  Uterosacral ligament vault suspension: five-year outcomes.

Authors:  W Andre Silva; Rachel N Pauls; Jeffrey L Segal; Christopher M Rooney; Steven D Kleeman; Mickey M Karram
Journal:  Obstet Gynecol       Date:  2006-08       Impact factor: 7.661

7.  Polyglactin 910 suture absorption and the role of cellular enzymes.

Authors:  T N Salthouse; B F Matlaga
Journal:  Surg Gynecol Obstet       Date:  1976-04

8.  A midurethral sling to reduce incontinence after vaginal prolapse repair.

Authors:  John T Wei; Ingrid Nygaard; Holly E Richter; Charles W Nager; Matthew D Barber; Kim Kenton; Cindy L Amundsen; Joseph Schaffer; Susan F Meikle; Cathie Spino
Journal:  N Engl J Med       Date:  2012-06-21       Impact factor: 91.245

9.  Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery.

Authors:  Jennifer M Wu; Catherine A Matthews; Mitchell M Conover; Virginia Pate; Michele Jonsson Funk
Journal:  Obstet Gynecol       Date:  2014-06       Impact factor: 7.661

10.  Sensory neuropathy following suspension of the vaginal apex to the proximal uterosacral ligaments.

Authors:  T Ignacio Montoya; Hillary I Luebbehusen; Joseph I Schaffer; Clifford Y Wai; David D Rahn; Marlene M Corton
Journal:  Int Urogynecol J       Date:  2012-05-16       Impact factor: 2.894

View more
  2 in total

Review 1.  Prolapse Repair Using Non-synthetic Material: What is the Current Standard?

Authors:  Ricardo Palmerola; Nirit Rosenblum
Journal:  Curr Urol Rep       Date:  2019-10-14       Impact factor: 3.092

2.  Recurrent apical prolapse after high uterosacral ligament suspension - in a heterogenous cohort characterised by a high prevalence of previous pelvic operations.

Authors:  Katrine Dahl Pedersen; Marie Højriis Storkholm; Karl Møller Bek; Marianne Glavind-Kristensen; Susanne Greisen
Journal:  BMC Womens Health       Date:  2019-07-12       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.